by Richard Harvey | Mar 29, 2026 | Interesting articles on nose and sinus disease, Nose and Sinus Blog
Repairing a spontaneous nasal CSF leak in the lateral sphenoid is one of the more misunderstood operations in endoscopic skull base surgery. At a recent national meeting, I was struck by how often panelists used the term “transpterygoid approach” while clearly...
by Richard Harvey | Mar 22, 2026 | Nose and Sinus Blog
The management of chronic rhinosinusitis (CRS)—particularly diffuse type-2 disease such as CRSwNP or eosinophilic CRS—has entered a new era. Biologic therapies have transformed outcomes. But an important question remains: Can biologics replace surgery—or is the...
by Richard Harvey | Mar 15, 2026 | Interesting articles on nose and sinus disease, Nose and Sinus Blog
Why “Chronic Sinusitis” and “Nasal Polyps” Are Misleading Terms Understanding why modern rhinology is moving beyond these outdated disease labels For decades, patients and doctors alike have used the term chronic sinusitis to describe persistent inflammation of the...
by Richard Harvey | Mar 8, 2026 | Interesting articles on nose and sinus disease, Nose and Sinus Blog, Uncategorized
Why “Blocked Nose” Doesn’t Always Mean Blocked Airflow The importance of objective testing in nasal breathing Many patients come to clinic saying they have a “blocked nose” or “nasal congestion.” It is one of the most common symptoms in ENT practice. Yet what patients...
by Richard Harvey | Mar 1, 2026 | Interesting articles on nose and sinus disease, Nose and Sinus Blog
Remission in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): Why “Feeling Better” Is No Longer Enough For years, success in chronic rhinosinusitis with nasal polyps (CRSwNP) meant one thing: the patient feels better. But in 2025, that is no longer our goal. With...
by Richard Harvey | Feb 22, 2026 | Interesting articles on nose and sinus disease, Nose and Sinus Blog
HHT Nosebleeds Treatment in Australia: A Specialist ENT Algorithm for Refractory Epistaxis Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder characterised by fragile, abnormal blood vessels. The most common and often most disabling...
